← Leaderboards
Josiah D Rich
Miriam Hospital
$21,388,960
Attributed
$31,773,128
Total exposure
15
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.8M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$49,814,009 · 15
CDC$1,087,491 · 1
By mechanism
P20$24,423,446 · 3
R01$19,888,067 · 7
T32$2,722,371 · 1
K24$1,713,849 · 1
R21$1,462,233 · 3
R34$691,534 · 1
Top collaborators
- Timothy P Flanigan7 shared
- Peter D. Friedmann6 shared
- Michael Scott Gordon6 shared
- Liza Solomon6 shared
- Traci C Green5 shared
- Mary A Carskadon3 shared
- Jaclyn White Hughto3 shared
- Kirsten Johnson Langdon3 shared
Others in their field
Top investigators on “United States”
- Leonard Freedman · Leidos Biomedical Research, Inc.$818,172,357
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Lawrence Corey · Fred Hutchinson Cancer Center$638,373,375
- David Heimbrook · Leidos Biomedical Research, Inc.$632,657,800
- Bambra Strokes · Ppd Development Lp$526,656,217
- Tracy L Nolen · Research Triangle Institute$474,487,152
Research focus
United StatesPharmaceutical PreparationsOverdoseResearch PersonnelImprisonmentProgramsCaringRhode IslandInnovationCommunitiesDrug UsageAddictionFundingBasePoliciesPreventionSiteMentorsOpioid Use DisorderPersonsOpioidResourcesLinkJail
Grant awards (83)
COBRE Center on Opioids and Overdose$2,068,716
P20 · FY2025 · GM · contact PI
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation$1,023,443
R01 · FY2025 · DA
Administrative Core$712,862
P20 · FY2025 · GM · contact PI
HIV and Other Infectious Consequences of Substance Use$555,196
T32 · FY2025 · DA · contact PI
COBRE Center on Opioids and Overdose$2,424,344
P20 · FY2024 · GM · contact PI
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation$1,038,035
R01 · FY2024 · DA
Administrative Core$994,679
P20 · FY2024 · GM · contact PI
HIV and Other Infectious Consequences of Substance Use$557,680
T32 · FY2024 · DA · contact PI
Integrating Long-Acting Injectable Treatment to Improve Medication Adherence among Persons Living with HIV and Opioid Use Disorder$225,600
R34 · FY2024 · DA
COBRE Center on Opioids and Overdose$2,498,628
P20 · FY2023 · GM · contact PI
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation$1,184,141
R01 · FY2023 · DA
Administrative Core$1,027,993
P20 · FY2023 · GM · contact PI
Preventing Overdoses Involving Stimulants (POINTS)Study$362,494
R01 · FY2023 · CE
HIV and Other Infectious Consequences of Substance Use$257,719
T32 · FY2023 · DA
Integrating Long-Acting Injectable Treatment to Improve Medication Adherence among Persons Living with HIV and Opioid Use Disorder$225,624
R34 · FY2023 · DA
Evaluating the decriminalization of non-prescribed buprenorphine in Rhode Island$194,472
R21 · FY2023 · DA
COBRE Center on Opioids and Overdose$2,205,702
P20 · FY2022 · GM · contact PI
Administrative Core$548,449
P20 · FY2022 · GM · contact PI
Preventing Overdoses Involving Stimulants (POINTS)Study$362,498
R01 · FY2022 · CE
Evaluating the decriminalization of non-prescribed buprenorphine in Rhode Island$250,221
R21 · FY2022 · DA
HIV and Other Infectious Consequences of Substance Abuse$250,053
T32 · FY2022 · DA
Integrating Long-Acting Injectable Treatment to Improve Medication Adherence among Persons Living with HIV and Opioid Use Disorder$240,310
R34 · FY2022 · DA
COBRE Center on Opioids and Overdose$134,624
P20 · FY2022 · GM · contact PI
COBRE Center on Opioids and Overdose$2,409,022
P20 · FY2021 · GM · contact PI
Administrative Core$487,720
P20 · FY2021 · GM · contact PI
Preventing Overdoses Involving Stimulants (POINTS)Study$362,499
R01 · FY2021 · CE
HIV and Other Infectious Consequences of Substance Abuse$235,101
T32 · FY2021 · DA
Evaluation of Low Threshold Buprenorphine Treatment in the Context of COVID-19$27,133
P20 · FY2021 · GM · contact PI
COBRE Center on Opioids and Overdose$2,376,689
P20 · FY2020 · GM · contact PI
Administrative Core$580,512
P20 · FY2020 · GM · contact PI
HIV and Other Infectious Consequences of Substance Abuse$231,446
T32 · FY2020 · DA
COBRE Center on Opioids and Overdose$2,428,175
P20 · FY2019 · GM · contact PI
Implementation to motivate physician response to opioid dependence in HIVsetting$669,096
R01 · FY2019 · DA
Administrative Core$455,733
P20 · FY2019 · GM · contact PI
HIV and Other Infectious Consequences of Substance Abuse$219,458
T32 · FY2019 · DA
COBRE Center on Opioids and Overdose$2,555,339
P20 · FY2018 · GM · contact PI
Implementation to motivate physician response to opioid dependence in HIVsetting$769,749
R01 · FY2018 · DA
Administrative Core$487,126
P20 · FY2018 · GM · contact PI
Evaluating the implementation and impact of a novel medication assisted treatment program in a unified jail and prison system$233,301
R21 · FY2018 · DA · contact PI
DAT-Optimizing the impact of medication assisted treatment interventions in prison and jail settings$215,006
R21 · FY2018 · DA · contact PI
HIV and Other Infectious Consequences of Substance Abuse$211,125
T32 · FY2018 · DA
Implementation to motivate physician response to opioid dependence in HIVsetting$680,443
R01 · FY2017 · DA
Evaluating the implementation and impact of a novel medication assisted treatment program in a unified jail and prison system$215,157
R21 · FY2017 · DA · contact PI
HIV and Other Infectious Consequences of Substance Abuse$204,593
T32 · FY2017 · DA
HIV and addictions among criminal justice-involved populations.$174,809
K24 · FY2017 · DA · contact PI
HIV and addictions among criminal justice-involved populations.$174,809
K24 · FY2016 · DA · contact PI
Implementation to motivate physician response to opioid dependence in HIVsetting$769,194
R01 · FY2015 · DA
HIV and addictions among criminal justice-involved populations.$174,809
K24 · FY2015 · DA · contact PI
A Randomized Controlled Trial and Cohort Study of HIV Testing and Linkage to Care$131,653
R01 · FY2015 · DA
Implementation to motivate physician response to opioid dependence in HIV setting$99,742
R01 · FY2015 · DA
Implementation to motivate physician response to opioid dependence in HIV setting$774,599
R01 · FY2014 · DA
Improving Linkage to HIV Care Following Release from Incarceration$698,796
R01 · FY2014 · DA · contact PI
A Randomized Controlled Trial and Cohort Study of HIV Testing and Linkage to Care$400,607
R01 · FY2014 · DA
HIV and addictions among criminal justice-involved populations.$174,809
K24 · FY2014 · DA · contact PI
Improving Linkage to HIV Care Following Release from Incarceration$792,187
R01 · FY2013 · DA · contact PI
A Randomized Controlled Trial and Cohort Study of HIV Testing and Linkage to Care$654,674
R01 · FY2013 · DA
A Randomized Trial of Continued Methadone Maintenance vs. Detoxification in Jail$314,262
R01 · FY2013 · DA · contact PI
HIV and addictions among criminal justice-involved populations.$174,809
K24 · FY2013 · DA · contact PI
Improving Linkage to HIV Care Following Release from Incarceration$916,164
R01 · FY2012 · DA · contact PI
A Randomized Controlled Trial and Cohort Study of HIV Testing and Linkage to Care$685,112
R01 · FY2012 · DA
A Randomized Trial of Continued Methadone Maintenance vs. Detoxification in Jail$453,040
R01 · FY2012 · DA · contact PI
Midcareer Investigator Award in Patient Oriented Research$172,085
K24 · FY2012 · DA · contact PI
Prisoner Overdose Training and Naloxone Upon Release$156,796
R21 · FY2012 · DA · contact PI
Improving Linkage to HIV Care Following Release from Incarceration$90,520
R01 · FY2012 · DA · contact PI
Improving Linkage to HIV Care Following Release from Incarceration$825,247
R01 · FY2011 · DA · contact PI
A Randomized Controlled Trial and Cohort Study of HIV Testing and Linkage to Care$731,641
R01 · FY2011 · DA
A Randomized Trial of Continued Methadone Maintenance vs. Detoxification in Jail$548,013
R01 · FY2011 · DA · contact PI
Prisoner Overdose Training and Naloxone Upon Release$197,280
R21 · FY2011 · DA · contact PI
Midcareer Investigator Award in Patient Oriented Research$171,985
K24 · FY2011 · DA · contact PI
A Randomized Controlled Trial and Cohort Study of HIV Testing and Linkage to Care$738,672
R01 · FY2010 · DA
Improving Linkage to HIV Care Following Release from Incarceration$704,163
R01 · FY2010 · DA · contact PI
A Randomized Trial of Continued Methadone Maintenance vs. Detoxification in Jail$553,310
R01 · FY2010 · DA · contact PI
Midcareer Investigator Award in Patient Oriented Research$168,549
K24 · FY2010 · DA · contact PI
A Randomized Trial of Continued Methadone Maintenance vs. Detoxification in Jail$153,723
R01 · FY2010 · DA · contact PI
A Randomized Trial of Continued Methadone Maintenance vs. Detoxification in Jail$523,473
R01 · FY2009 · DA · contact PI
Opiate Replacement Therapy at Release from Incarceration$341,487
R01 · FY2009 · DA · contact PI
Midcareer Investigator Award in Patient Oriented Research$165,212
K24 · FY2009 · DA · contact PI
Opiate Replacement Therapy at Release from Incarceration$410,283
R01 · FY2008 · DA · contact PI
Midcareer Investigator Award in Patient Oriented Research$161,973
K24 · FY2008 · DA · contact PI
Opiate Replacement Therapy at Release from Incarceration$341,772
R01 · FY2007 · DA · contact PI
Opiate Replacement Therapy at Release from Incarceration$70,200
R01 · FY2007 · DA · contact PI
Opiate Replacement Therapy at Release from Incarceration$351,980
R01 · FY2006 · DA · contact PI
Opiate Replacement Therapy at Release from Incarceration$361,155
R01 · FY2005 · DA